Elite Vigilance actively uses industry-recognised AI-enabled pharmacovigilance platforms as part of service delivery to support accuracy, efficiency, and consistency across safety operations. These tools are embedded within defined workflows to manage high-volume, data-intensive activities, while medical evaluation, regulatory interpretation, and safety decisions remain under the oversight of qualified pharmacovigilance professionals.
Elite Vigilance delivers pharmacovigilance services using LifeSphere Safety to support end-to-end safety operations, including case intake, processing, coding, and reporting. AI-enabled capabilities improve data consistency, workflow efficiency, and scalability across products, regions, and regulatory frameworks.
Elite Vigilance performs pharmacovigilance activities within Oracle Argus Safety environments, supporting adverse event case management, global regulatory reporting, and safety analytics. The platform enables structured data handling, reliable submissions, and consistent compliance with international pharmacovigilance reporting requirements.
Elite Vigilance uses Cora PVAI within pharmacovigilance operations to support automated case intake, data extraction, and coding activities. AI-assisted workflows reduce manual effort, improve turnaround times, and enhance accuracy while maintaining full medical review and regulatory oversight.
Elite Vigilance applies TCS ADD Safety within pharmacovigilance programs to support integrated safety analytics and signal monitoring. Advanced machine learning capabilities enable structured analysis of safety data, supporting informed medical assessment and effective risk evaluation across complex product portfolios.
Elite Vigilance uses Linguamatics I2E in pharmacovigilance literature screening to identify safety-relevant information from global scientific publications. Natural language processing enables efficient review of large volumes of content while ensuring systematic documentation and regulatory-compliant surveillance.
Elite Vigilance utilises VigiLanz within pharmacovigilance activities to support real-time monitoring of post-marketing safety data. AI-driven analysis of healthcare information helps identify potential adverse event patterns and supports proactive medication safety oversight.
Elite Vigilance uses Saama LSAC within pharmacovigilance operations to support active safety surveillance and predictive analytics. Machine learning models help analyse real-world data trends, supporting early signal evaluation and evidence-based safety decision-making.
We use AI-enabled tools to support data handling, workflow management, and safety monitoring activities. These tools improve accuracy and processing efficiency, enabling our teams to focus on scientific evaluation and regulatory decision-making rather than manual administrative tasks.
Absolutely not. AI handles repetitive, time-consuming tasks, freeing our medical reviewers to focus on complex clinical assessments and critical decision-making. This combination of intelligent automation and expert human oversight actually improves quality while reducing processing time. Every case receives a thorough medical evaluation by qualified professionals.
Our AI-enhanced workflow processes straightforward cases 40-60% faster than traditional methods. Automated intake, intelligent data extraction, and smart coding suggestions accelerate initial processing, while medical reviewers focus on clinical evaluation. Urgent, serious cases are prioritised automatically, ensuring regulatory deadlines are consistently met.
No. Our AI platform uses transfer learning and pre-trained models that adapt quickly to new products and therapeutic areas. Initial configuration typically takes 3-5 days rather than weeks. The system learns your product-specific terminology, expected adverse event profiles, and organisational preferences as it processes cases, continuously improving accuracy without requiring constant manual retraining.
Traditional duplicate detection relies on exact matches of patient identifiers, which misses many duplicates with slight variations. Our AI uses probabilistic matching algorithms that consider patient age ranges, event timing, reporter similarities, geographical proximity, and narrative content similarities, detecting duplicates even when reported details differ significantly. This prevents over-reporting and provides more accurate safety profiles.
AI-powered tools help streamline processes, reduce repetitive manual tasks, and improve overall efficiency. This allows safety teams to focus more on analysis, oversight, and regulatory responsibilities rather than administrative workload.
Our intelligent intake system automatically extracts key information from emails, faxes, web forms, and call centre transcripts. AI classifies case urgency based on seriousness criteria, identifies expedited reporting requirements, routes cases to appropriate reviewers based on therapeutic expertise, and flags incomplete information requiring follow-up, all within minutes of receipt rather than hours.
Our AI systems continuously learn from every case processed across our client base (while maintaining confidentiality through anonymised learning). Major model updates occur quarterly, incorporating regulatory changes, improved algorithms, and expanded medical vocabularies. Emergency updates deploy within 48 hours when critical regulatory requirements change. All updates undergo validation before production deployment.
All AI recommendations undergo human expert review before finalisation. When reviewers override AI suggestions, the system logs these corrections and learns from them, improving future accuracy. We maintain detailed performance metrics that track AI accuracy across different functions, and if accuracy drops below defined thresholds in any area, automatic alerts trigger immediate investigation and recalibration.
While specific savings vary by case volume and complexity, clients typically see 30-50% cost reduction compared to traditional manual processing services. AI eliminates redundant manual work, reduces error-related rework, accelerates processing (reducing labour hours), minimises submission rejections, and enables earlier signal detection (preventing costly late-stage safety issues). Most importantly, you receive superior quality at a lower cost.
